Benign prostatic hyperplasia (BPH), for a long time known as benign prostatic hypertrophy, is so widespread that many researchers say, it inevitably occurs in men who have lived long enough for BPH to develop.
KB Kolontarev, GR Kasyan
doaj +1 more source
Applications of Vertebrate Models in Studying Prostatitis and Inflammation-Associated Prostatic Diseases. [PDF]
Bleeker J, Wang ZA.
europepmc +1 more source
Correction: Estimating patient health in prostate cancer treatment counseling. [PDF]
Chesnut GT +7 more
europepmc +1 more source
Oxidative Stress Links Aging-Associated Cardiovascular Diseases and Prostatic Diseases. [PDF]
Zhao MJ +5 more
europepmc +1 more source
Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study [PDF]
To assess the impact of statin use on biochemical recurrence (BCR) of prostate cancer after radical prostatectomy (RP)
Cattarino, Susanna +8 more
core
Increased SPC24 in prostatic diseases and diagnostic value of SPC24 and its interacting partners in prostate cancer. [PDF]
Chen S +13 more
europepmc +1 more source
Update on Laboratory Diagnosis and Epidemiology of \u3cem\u3eTrichomonas vaginalis\u3c/em\u3e: You Can Teach an “Old” Dog “New” Trichs [PDF]
Past viewpoints on Trichomonas vaginalis infection have characterized the associated clinical disease as a “nuisance” condition, with affected demographics largely being older African American females residing in urban centers.
Munson, Erik +2 more
core +1 more source
Discovery proteomics defines androgen-regulated glycoprotein networks in prostate cancer cells, as well as putative biomarkers of prostatic diseases. [PDF]
Hsiao JJ +4 more
europepmc +1 more source
Tamsulosin � turn a round [PDF]
Tamsulosin is a sulfamoylphen-ethylamine derivative, a potent and a selective antagonist of Alpha-1A adrenoceptor. It s approved in the treatment of LUTS in BPH disease, being a specific Alpha -1A blocker it does not interfere much with the ...
Praveen R, Int J Cur Bio Med Sci.
core
A brief review of the literature on the malignant ureteral obstruction [PDF]
Malignant ureteral obstruction (MUO) caused by a primarily urological tumor or secondary to a late-stage malignancy can be difficult for the urologist to manage. Due to a lack of clinical data on the management of MUO, every case is particular and should
Brînză, Adrian +7 more
core +1 more source

